CH594588A5 - - Google Patents

Info

Publication number
CH594588A5
CH594588A5 CH818674A CH818674A CH594588A5 CH 594588 A5 CH594588 A5 CH 594588A5 CH 818674 A CH818674 A CH 818674A CH 818674 A CH818674 A CH 818674A CH 594588 A5 CH594588 A5 CH 594588A5
Authority
CH
Switzerland
Application number
CH818674A
Inventor
John Carl Dr Godfrey
John Edwin Dr Macnintch
Joseph Dr Rubinfeld
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH594588A5 publication Critical patent/CH594588A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
CH818674A 1973-06-15 1974-06-14 CH594588A5 ( )

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/370,506 US3952096A (en) 1973-06-15 1973-06-15 Mixture of calcium carbonate and calcium-α-p-chlorophenoxyisobutyrate as an antihyperlipemic agent

Publications (1)

Publication Number Publication Date
CH594588A5 true CH594588A5 ( ) 1978-01-13

Family

ID=23459961

Family Applications (1)

Application Number Title Priority Date Filing Date
CH818674A CH594588A5 ( ) 1973-06-15 1974-06-14

Country Status (17)

Country Link
US (1) US3952096A ( )
JP (1) JPS5031018A ( )
BE (1) BE815143A ( )
CA (1) CA1038402A ( )
CH (1) CH594588A5 ( )
DE (1) DE2428639A1 ( )
DK (1) DK316374A ( )
FI (1) FI178174A ( )
FR (1) FR2233043B1 ( )
GB (1) GB1469457A ( )
IE (1) IE39276B1 ( )
IL (1) IL45014A ( )
NL (1) NL7407847A ( )
NO (1) NO742027L ( )
PH (1) PH13350A ( )
SE (1) SE7407561L ( )
ZA (1) ZA743124B ( )

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573487A (en) * 1977-05-23 1980-08-28 Bristol Myers Co Bile acid binding composition
FR2428629A1 (fr) * 1978-06-14 1980-01-11 Hexachimie Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique
US4591500A (en) * 1983-04-25 1986-05-27 Microencapsulation S.A. Tablet having the shape of a capsule, process and device for its preparation
US4824672A (en) * 1986-06-06 1989-04-25 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
HU217629B (hu) * 1991-12-12 2000-03-28 Novartis Ag. Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) * 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
US20060111346A1 (en) * 2004-11-23 2006-05-25 Fazix Corporation. Methods of modulating high-density lipoprotein cholesterol levels and pharmaceutical formulations for the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
CH515207A (de) * 1966-06-27 1971-11-15 Sandoz Ag Verfahren zur Herstellung von neuen Bis-(p-Chlorphenoxy)-essigsäureestern

Also Published As

Publication number Publication date
BE815143A (fr) 1974-11-18
PH13350A (en) 1980-03-20
IE39276L (en) 1974-12-15
AU6992074A (en) 1975-12-11
NO742027L ( ) 1975-01-13
CA1038402A (en) 1978-09-12
GB1469457A (en) 1977-04-06
IL45014A0 (en) 1974-09-10
DE2428639A1 (de) 1975-01-09
DK316374A ( ) 1975-02-10
FI178174A ( ) 1974-12-16
FR2233043A1 ( ) 1975-01-10
JPS5031018A ( ) 1975-03-27
IL45014A (en) 1978-01-31
IE39276B1 (en) 1978-09-13
US3952096A (en) 1976-04-20
SE7407561L ( ) 1974-12-16
FR2233043B1 ( ) 1978-07-21
ZA743124B (en) 1975-05-28
NL7407847A ( ) 1974-12-17

Similar Documents

Publication Publication Date Title
AU476761B2 ( )
AU474593B2 ( )
AU474511B2 ( )
AU474838B2 ( )
AU476714B2 ( )
FI178174A ( )
AU476696B2 ( )
AR199451A1 ( )
AU477823B2 ( )
AR196382A1 ( )
AR200256A1 ( )
AR197627A1 ( )
AR195948A1 ( )
AU476873B1 ( )
AR195311A1 ( )
AU477824B2 ( )
AR193950A1 ( )
AR196212Q ( )
AR196123Q ( )
CH562026A5 ( )
AU479458A ( )
CH562972A5 ( )
CH563536A5 ( )
CH561642A5 ( )
CH560567A5 ( )

Legal Events

Date Code Title Description
PL Patent ceased